NLRP3 and Alzheimer disease: When data were analysed in AD and HC separately, results were as follows: (1) a significantly higher inflammasome activation in AD compared to HC monocytes; and (2) a similar dampening effect on NLRP3 activation in both AD and HC as stated by the reduction of both ASC-speck formation and caspase-1 and IL-18 production.